Drug
lazertinib
Marketed as LAZCLUZE.
Generic name
lazertinib
Brand names
LAZCLUZE
First FDA approval
2024-08-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA219008 | LAZCLUZE | 2024-08-19 | JANSSEN BIOTECH |
Manufacturers
JANSSEN BIOTECH
Frequently asked questions
When was lazertinib FDA approved?
Earliest FDA approval on record: 2024-08-19.
What brand names are sold as lazertinib?
LAZCLUZE.
Sources
Appeal a lazertinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com